https://pubmed.ncbi.nlm.nih.gov/34215766/
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
In metastatic breast cancer (mBC), the change of human epidermal growth factor receptor 2 (HER2) status between primary and metastatic lesions is widely...